Satpal Khattar Portfolio Shareholdings and Investments in 2026

Latest Satpal Khattar Stock Portfolio & Holdings (2026)
Satpal Khattar Portfolio Stock Screener
Satpal Khattar Portfolio Stock Screener: Analyse & Filter Indian Stocks on Tickertape
Created by
@tickertapetickertapeShowing 1 - 6 of 6 results
| NameStocks (6)↓ | ↓Sub-SectorSub-Sector↓ | ↓Market CapMarket Cap↓ | ↓Close PriceClose Price↓ | ↓PE RatioPE Ratio↓ | ↓1D Return1D Return↓ | ↓1M Return1M Return↓ | ↓6M Return6M Return↓ | ↓1Y Return1Y Return↓ | ↓PB RatioPB Ratio↓ | ↓Return on EquityReturn on Equity↓ | ↓ROCEROCE↓ | ↓Dividend YieldDiv Yield↓ | ↓Debt to EquityDebt to Equity↓ | ↓Volatility vs NiftyVolatility vs Nifty↓ | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Strides Pharma Science LtdSTAR | PharmaceuticalsPharmaceuticals | 8,391.408,391.40 | 1,001.151,001.15 | 2.342.34 | 0.110.11 | 10.4310.43 | 20.6120.61 | 61.6361.63 | 3.243.24 | 154.29154.29 | 117.56117.56 | 0.440.44 | 0.730.73 | 2.842.84 | |
| 2. | RPP Infra Projects LtdRPPINFRA | Construction & EngineeringConstruction & Engineering | 308.42308.42 | 73.8373.83 | 4.724.72 | -1.60-1.60 | 5.475.47 | -38.80-38.80 | -54.26-54.26 | 0.580.58 | 13.6713.67 | 18.9518.95 | -- | 0.080.08 | 3.483.48 | |
| 3. | Gayatri Projects LtdGAYAPROJ | Construction & EngineeringConstruction & Engineering | 261.89261.89 | 17.1917.19 | 2.112.11 | 4.954.95 | 28.9628.96 | 56.4156.41 | 169.44169.44 | -0.18-0.18 | -- | -11.22-11.22 | -- | -- | 3.343.34 | |
| 4. | Nath Bio-Genes (I) LtdNATHBIOGEN | Agro ProductsAgro Products | 255.07255.07 | 172.94172.94 | 6.616.61 | 13.0813.08 | 20.0120.01 | -1.93-1.93 | 11.6511.65 | 0.400.40 | 6.166.16 | 7.757.75 | 1.491.49 | 0.190.19 | 2.502.50 | |
| 5. | Dcm LtdDCM | ConglomeratesConglomerates | 109.30109.30 | 69.3969.39 | 4.994.99 | 2.062.06 | 13.9413.94 | -29.70-29.70 | -31.65-31.65 | 2.552.55 | 68.8068.80 | 40.1040.10 | -- | 0.030.03 | 2.822.82 | |
| 6. | Gayatri Highways LtdGAYAHWS | Construction & EngineeringConstruction & Engineering | 47.9347.93 | 2.292.29 | 0.040.04 | -2.55-2.55 | 0.440.44 | -34.38-34.38 | 65.9465.94 | -0.15-0.15 | -- | 466.10466.10 | -- | -- | 3.993.99 |
Selection criteria: The table contains publicly disclosed Satpal Khattar investment portfolio as on 24th March 2026. Stocks are sorted by market capitalisation, highest to lowest.
Satpal Khattar's Bulk and Block Deals
Bulk and block deals improve market transparency and explain sharp changes in stock volumes. These disclosures help track where large investors deploy capital and which sectors attract or lose interest over time. Analysts often review such deals to understand portfolio shifts and changing market sentiment.
Here's how you can find the latest bulk and block deals by Satpal Khattar:
- Open Market Movers
- Under Party, type Satpal Khattar
- Select the relevant Category and Transaction Type
The results show Satpal Khattar's latest bulk and block deals. The platform also allows date filtering to review historical transactions and identify patterns over time.
Satpal Khattar Investor Profile
Satpal Khattar is an Indian-born Singaporean lawyer, businessman, and investor, born on 22 November 1942 in Bhera, British India (now in Pakistan). He moved to Singapore in the 1950s and studied law at the University of Singapore. After working in Singapore's public legal service, he founded KhattarWong LLP in 1974, which grew into a leading law firm. Following his retirement from legal practice in 2000, he established Khattar Holdings, a private investment firm managing investments across India, Southeast Asia, the UK, and Eastern Europe. In 2011, the Government of India awarded him the Padma Shri.
- Name: Satpal Khattar (Sat Pal Khattar)
- Nationality: Singaporean (Indian-born)
- Education: LLB (Hons), University of Singapore (1966); LLM, University of Singapore (1970)
- Investment vehicle: Khattar Holdings (Singapore-based private investment firm)
- India investing since: Early 1990s
- Disclosed portfolio value (₹): ~₹154.8 cr.(as per Dec 2025 filings)
- No. of disclosed portfolio companies: 6 stocks (Dec 2025)
- Primary focus: Long-term value investing across pharmaceuticals, infrastructure, agri-biotech, and industrials
- Notable award: Padma Shri, Government of India (2011) — first Singapore resident to receive the honour
Khattar Holdings maintains a diversified portfolio across real assets, listed equities, and private equity, with investments spanning India, Southeast Asia, the UK, and Eastern Europe. He is also co-chairman of the Singapore-India Partnership Foundation, which fosters bilateral trade and investment between Singapore and India.
Overview of Stocks in Satpal Khattar's Portfolio
Strides Pharma Science Ltd
Strides Pharma Science is a global specialty pharmaceutical company focused on regulated markets including the United States, Australia, and Europe. It manufactures and markets complex generics, over-the-counter products, and branded pharmaceuticals, with a strong presence in soft gelatin capsules and sterile injectables.
Gayatri Projects Ltd
Gayatri Projects is a Hyderabad-based infrastructure and construction company specialising in roads and highways, irrigation, industrial structures, and mining projects. The company has executed large-scale civil engineering projects across India.
Nath Bio-Genes (I) Ltd
Nath Bio-Genes is an agricultural biotechnology company engaged in the research, development, and marketing of hybrid seeds across a range of field crops including cotton, vegetables, and cereals. The company operates primarily in India and serves farmers across multiple states.
RPP Infra Projects Ltd
RPP Infra Projects is a civil construction company focused on water supply and sanitation projects, roads, bridges, and irrigation infrastructure. It operates primarily in South India and has a track record in government-funded infrastructure contracts.
Gayatri Highways Ltd
Gayatri Highways is an infrastructure holding company with stakes in road concession assets developed under the BOT (Build-Operate-Transfer) model. It is closely linked to the Gayatri Projects group and holds interests in operational highway projects across India.
DCM Ltd
DCM Ltd is a diversified company with interests across textiles, chemicals, and real estate. The company has a long operating history in India and has gradually shifted focus toward asset monetisation and restructuring of legacy businesses.
Satpal Khattar Portfolio Composition
The following table shows the publicly disclosed holdings of the Satpal Khattar portfolio based on the latest available shareholding filings.
| Stock Name | Holding Value (in cr.) | Quantity Held | Holding Percent (%) | Change from Previous Qtr (%) |
|---|---|---|---|---|
| Strides Pharma Science Ltd | 131.7 | 1,474,942 | 1.60 | 0.00 |
| Gayatri Projects Ltd | 9.6 | 7,179,335 | 3.80 | 0.00 |
| Nath Bio-Genes (I) Ltd | 5.6 | 400,000 | 2.10 | New |
| RPP Infra Projects Ltd | 5.5 | 797,374 | 1.60 | -0.50 |
| Gayatri Highways Ltd | 1.2 | 5,179,335 | 2.20 | 0.00 |
| DCM Ltd | 1.2 | 200,000 | 1.10 | 0.00 |
How to Invest in Satpal Khattar Portfolio Stocks?
Here's how you can invest in Satpal Khattar portfolio stocks using Tickertape -
- Create an account on the Tickertape or log in if you already have one.
- Open Satpal Khattar Portfolio Screener
- Filter stocks based on 200+ parameters. Tickertape provides comprehensive data on each stock, including financials, performance metrics, future projections, red flags, and more. You can review this data to assess each company's financial health and potential in-depth.
- Once you've decided on a stock, you can place a buy order through your brokerage account linked to Tickertape.
You can stay updated with each of your favourite stocks' alerts and announcements with Tickertape Alerts. Further, you can analyse your overall portfolio and potential red flags in it by connecting it to Tickertape. Check out the detailed analysis of your portfolio now!
Satpal Khattar Net Worth
As per corporate shareholdings filed for December, 2025, Satpal Khattar publicly holds 6 stocks with a disclosed net worth of over ₹154.8 cr. His total wealth, which includes private holdings through Khattar Holdings, real estate, and other investments across India, Southeast Asia, the UK, and Eastern Europe, is significantly larger than what is reflected in this disclosed Indian listed equity portfolio.
Satpal Khattar's Investment Strategy
Long-Term Value Investing
Diversification Across Sectors and Geographies
High-Conviction, Low-Turnover Holdings
Focus on Mid and Small-Cap Companies
Learnings From Satpal Khattar's Portfolio
Early-Mover Advantage in India
Steady Conviction Over Market Cycles
Exposure to India's Infrastructure Build-Out
Singapore-India Bilateral Investment Perspective
Receive real-time market alerts for timely decisions
Monitor your portfolio from the palm of your hands
Watchlist stocks and mutual funds to stay updated

Satpal Khattar's Portfolio: Sector Allocation
Pharmaceuticals
Infrastructure and Construction
Road Concessions
Agri-Biotech
Conclusion
Satpal Khattar has built a long-standing presence in Indian equities through Khattar Holdings, his Singapore-based private investment firm. The portfolio reflects a focused approach with long holding periods and exposure to multiple segments of the Indian economy.
Public disclosures of prominent investor portfolios offer useful insights into sector exposure and institutional positioning. However, investment decisions vary based on individual objectives, risk tolerance, and time horizons.
For independent stock analysis, investors can explore companies using the Tickertape Stock Screener, which offers 200+ filters to analyse fundamentals, valuations, and financial strength. Investors can also track major stock activity and prominent investor movements through Tickertape Market Movers.
Popular Stock Collections
Popular Mutual Fund Collections
Frequently Asked Questions About the Satpal Khattar Portfolio
Who is Satpal Khattar?
Satpal Khattar is an Indian-born Singaporean lawyer, businessman, and community leader born on 22 November 1942. He is the founder of KhattarWong LLP, one of Singapore's largest law firms, and the chairman of Khattar Holdings, a private investment firm. He received the Padma Shri from the Government of India in 2011, the first Singapore resident to receive the honour. He has been investing in Indian equities and businesses since the early 1990s.What does the Satpal Khattar portfolio 2026 include?
As per corporate shareholdings filed for December 2025, Satpal Khattar publicly holds 6 stocks with a disclosed net worth of over ₹154.8 cr. The portfolio includes Strides Pharma Science, Gayatri Projects, Nath Bio-Genes (India), RPP Infra Projects, Gayatri Highways, and DCM Ltd.What stocks does Satpal Khattar hold?
As per the latest disclosed shareholding data (December 2025), Satpal Khattar holds: Strides Pharma Science Ltd Gayatri Projects Ltd Nath Bio-Genes (I) Ltd RPP Infra Projects Ltd Gayatri Highways Ltd DCM LtdWhere can I check Satpal Khattar's latest portfolio?
You can track Satpal Khattar's latest portfolio through quarterly shareholding data published by Indian stock exchanges and market-tracking platforms. Investors can also track portfolio changes, bulk and block deals, and other major stock activity using tools like Tickertape Market Movers.What is the net worth of Satpal Khattar?
As per corporate shareholdings filed for December, 2025, Satpal Khattar's publicly disclosed Indian equity portfolio is valued at over ₹154.8 cr. The figure reflects the market value of his reported holdings based on prevailing share prices and regulatory disclosures.What is Satpal Khattar's investment philosophy?
Satpal Khattar follows a long-term, value-oriented investment approach, preferring to hold positions across market cycles rather than trade for short-term gains. His India portfolio reflects a diversified strategy across pharmaceuticals, infrastructure, agri-biotech, and industrials, with most stakes unchanged over many quarters. He invests through Khattar Holdings, which maintains a broader portfolio of diversified assets across multiple geographies.What sectors does Satpal Khattar invest in?
Satpal Khattar's disclosed portfolio spans pharmaceuticals, infrastructure and civil construction, road concessions, agricultural biotechnology, and industrial businesses. These allocations reflect exposure to a mix of export-oriented sectors, domestic infrastructure activity, and India's agricultural ecosystem.